Abstract
The current global outbreaks of Monkeypox is a unique infectious disease in the way it seems to be transmitting: it has been observed to be highly concentrated in communities of men who have sex with men (MSM) through pair formation, and also provides immunity. This framework of mostly close, prolonged contact spreading a disease that admits immunity after infection is unlike similar infections which either offer little to no immunity post-infection or are lifelong infections. This creates the need for a new model framework that incorporates pair formation structure with recovery. While seemingly a straight forward model, we show how new dynamics arise from the combination of pair formation and recovery that are not present in a standard model with recovery and also not present in a pair formation model without recovery. We see that the combination of these two properties allows for waves of infection that are not seen in a standard SIR model. These dynamics suggest that outbreaks of monkeypox around the world may require special attention from public health. We also derive a reproduction number for this model and estimate the reproduction number of human monkeypox to be ≈ 2.3 using global and Canadian data. The expression derived for R0 can help estimate key parameters for diseases transmission and public health interventions and compare to equivalent models without pair formation.
Significance Statement With outbreaks of Monkeypox being observed around the world, a modeling framework which takes into account the unique properties of this emerging disease is necessary for understanding the disease and public health mitigation. Monkeypox seems to be unique in that it requires close, prolonged contact with an infected individual in order to spread, but also provides immunity after infection. We develop a model for this situation and show how this differs from simpler models which are currently being used for disease dynamics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by NSERC
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors have no competing interests.
Data Availability
All data produced are available online at https://health-infobase.canada.ca/monkeypox/
